首页> 外文期刊>AJNR. American journal of neuroradiology >Matrix(2) coils in embolization of intracranial aneurysms: 1-year outcome and comparison with bare platinum coil group in a single institution.
【24h】

Matrix(2) coils in embolization of intracranial aneurysms: 1-year outcome and comparison with bare platinum coil group in a single institution.

机译:颅内动脉瘤栓塞中的Matrix(2)线圈:1年结果并与单个机构中的裸铂线圈组进行比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: The endosaccular occlusion by using BPC has been useful in the treatment of intracranial aneurysms, but its limited durability remains a deep-seated drawback. The Matrix(2) coil, one of the bioactive-coated coils, had been developed to improve this limited durability. To evaluate durability of Matrix(2) coils after embolization of intracranial aneurysms, we retrospectively compared 1-year outcomes with that of BPC groups. MATERIALS AND METHODS: A group of 121 aneurysms in 114 patients were embolized by using Matrix(2) coils between April 2006 and September 2008. The BPC group consisted of 151 aneurysms in 137 patients embolized by using BPCs alone between October 2007 and October 2008. The initial outcomes including packing densities, occlusion grades, and periprocedural complications, and the 1-year outcomes on MR angiography were retrospectively compared between the 2 groups. RESULTS: The Matrix(2) coil group and BPC group with similar baseline demographic characteristics revealed comparable initial outcomes. The rates of overall recurrence, major recanalization, and retreatment were 17.4%, 14.0%, and 10.7% versus 7.3%, 5.3%, and 4.6%, respectively (P = .066). However, the rates of subgroups with aneurysm volumes between 50 and 200 mm(3) were 23.7%, 13.1%, and 10.5% versus 2.2%, 0%, and 0% (P = .022), respectively. The rates of subgroups with packing attenuation <30% were 38.3%, 31.9%, and 23.4% versus 13.3%, 11.7%, and 10% (P = .025), respectively. There were no differences in packing attenuation (P = .152), initial occlusion grade (P = .098), and 1-year outcomes (P = .209) according to the length of Matrix(2) coils used. CONCLUSIONS: Overall, initial and 1-year outcomes of the Matrix(2) coil group were comparable to those of the BPC group. However, in certain subgroups of aneurysm volume and packing attenuation, the 1-year durability of Matrix(2) coils was inferior to that of the BPC group.
机译:背景与目的:使用BPC进行囊内阻塞治疗颅内动脉瘤非常有用,但是其有限的耐用性仍然是一个深层次的缺陷。 Matrix(2)线圈是生物活性涂层线圈之一,已开发来改善这种有限的耐久性。为了评估颅内动脉瘤栓塞后Matrix(2)线圈的耐久性,我们回顾性比较了1年结果与BPC组的结果。材料与方法:在2006年4月至2008年9月之间,使用Matrix(2)线圈栓塞了114例患者的121个动脉瘤。在2007年10月至2008年10月之间,单独使用BPC栓塞的137例患者中的151个动脉瘤由BPC组组成。回顾性比较两组的初始结果,包括包装密度,闭塞程度和术中并发症,以及MR血管造影的1年结果。结果:基线人口统计学特征相似的Matrix(2)线圈组和BPC组显示出可比较的初始结果。总体复发率,大血管再通率和再治疗率分别为7.3%,5.3%和4.6%,分别为17.4%,14.0%和10.7%(P = .066)。但是,动脉瘤体积在50至200 mm(3)之间的亚组的比率分别为23.7%,13.1%和10.5%,而2.2%,0%和0%(P = .022)。装箱衰减<30%的亚组的发生率分别为38.3%,31.9%和23.4%,而分别为13.3%,11.7%和10%(P = .025)。根据使用的Matrix(2)线圈的长度,填充衰减(P = .152),初始咬合等级(P = .098)和1年结果(P = .209)没有差异。结论:Matrix(2)线圈组的总体,初始和1年结果与BPC组相当。但是,在某些动脉瘤体积和充盈衰减的亚组中,Matrix(2)线圈的1年耐用性不如BPC组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号